pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F

被引:0
|
作者
Yat Peng Chew
Mark Ellis
Scott Wilkie
Sibylle Mittnacht
机构
[1] Institute of Cancer Research,
[2] Chester Beatty Laboratory,undefined
来源
Oncogene | 1998年 / 17卷
关键词
retinoblastoma protein; pRB; E2F; phosphorylation; checkpoint control; cell cycle;
D O I
暂无
中图分类号
学科分类号
摘要
Progression of cells into S phase is controlled by the retinoblastoma protein (pRB) and relies on the functional inactivation of this tumour suppressor in late G1 via protein phosphorylation. We provide evidence here that, besides controlling entry of cells into S phase, pRB can operate to inhibit S phase completion. Differential arrays of phosphorylation appear to regulate these different events, suggesting that cycle progression at these two stages of the cell cycle may be achieved via activation of distinct downstream pRB effector pathways. In agreement with this hypothesis, pRB's ability to prevent S phase entry, but not its ability to inhibit S phase completion, correlates with repression of E2F-regulated promoters. Furthermore, ectopic expression of E2F or the E2F-regulated cyclin E gene promote S phase entry in cells expressing phosphorylation-defective pRB but neither is sufficient to trigger completion of S phase. Our findings raise the possibility that pRB, in addition to its well-established role in controlling a checkpoint in late G1, could be involved in the control of a further checkpoint operating during S phase and that implementation of this checkpoint relies on an as yet unidentified pRB effector distinct from E2F.
引用
收藏
页码:2177 / 2186
页数:9
相关论文
共 50 条
  • [41] Inhibition of pituitary tumors in Rb mutant chimeras through E2f4 loss reveals a key suppressive role for the pRB/E2F pathway in urothelium and ganglionic carcinogenesis
    Parisi, T.
    Bronson, R. T.
    Lees, J. A.
    ONCOGENE, 2009, 28 (04) : 500 - 508
  • [42] Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G(1) exit
    Hofmann, F
    Livingston, DM
    GENES & DEVELOPMENT, 1996, 10 (07) : 851 - 861
  • [43] A ROLE FOR THE E2F PRODUCT IN REGULATING CELL-CYCLE PROGRESSION
    NEVINS, JR
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 206 - 206
  • [44] Epstein-Barr virus replication within differentiated epithelia requires pRb sequestration of activator E2F transcription factors
    Schaal, Danielle L.
    Amucheazi, Akajiugo A.
    Jones, Sarah C.
    Nkadi, Ebubechukwu H.
    Scott, Rona S.
    JOURNAL OF VIROLOGY, 2024,
  • [45] pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes
    Hurford, RK
    Cobrinik, D
    Lee, MH
    Dyson, N
    GENES & DEVELOPMENT, 1997, 11 (11) : 1447 - 1463
  • [46] Problem-Solving Test: E2F: A family of S Phase Regulating Transcription Factors
    Szeberenyi, Jozsef
    BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION, 2014, 42 (01) : 88 - 90
  • [47] Transforming growth factor β inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells
    Hu, XT
    Cress, D
    Zhong, Q
    Zuckerman, KS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 276 (03) : 930 - 939
  • [48] Potent Anti-Tumor Effect Generated by a Novel Human Papillomavirus (HPV) Antagonist Peptide Reactivating the pRb/E2F Pathway
    Guo, Cai-ping
    Liu, Ke-wei
    Luo, Hai-bo
    Chen, Hong-bo
    Zheng, Yi
    Sun, Shen-nan
    Zhang, Qian
    Huang, Laiqiang
    PLOS ONE, 2011, 6 (03):
  • [49] Role for E2F is DNA damage-induced entry of cells into S phase
    Huang, YY
    Ishiko, T
    Nakada, S
    Utsugisawa, T
    Kato, T
    Yuan, ZM
    CANCER RESEARCH, 1997, 57 (17) : 3640 - 3643
  • [50] ANALYSIS OF P107-ASSOCIATED PROTEINS - P107 ASSOCIATES WITH A FORM OF E2F THAT DIFFERS FROM PRB-ASSOCIATED E2F-1
    DYSON, N
    DEMBSKI, M
    FATTAEY, A
    NGWU, C
    EWEN, M
    HELIN, K
    JOURNAL OF VIROLOGY, 1993, 67 (12) : 7641 - 7647